IPO registrations (S-1, F-1) · Registrants
MYOMO, INC.
- SEC CIK
- 1369290 · filings on EDGAR ↗
- Former names
- MYOMO INC (2006–2020)
- Registration
- Form S-1, first filed 2017-10-20, last 2023-01-11; 3 initial registrations, 12 amendments
- Outcome
- Final prospectus filed 2017-12-01; declared effective 2017-11-29
- Industry (SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies 3842
- Incorporated in
- DE
- Business address
- 137 PORTLAND STREET, 4TH FLOOR, Boston, MA 02114
- Ticker
- MYO (NYSE)
- EDGAR entity type
- operating
- Insiders and CEO pay
- MYOMO, INC. on the corporate pages
Offering terms
- Final price
- $2.40 per share (424B4 filed 2017-12-01)
- Shares sold
- 4,175,000
- Gross proceeds
- $10,020,000 before underwriting discounts and any over-allotment option
- Listing
- NYSE American under the symbol MYO
- Lead underwriters
- Roth Capital Partners (4,175,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: MYOMO INC. Fuzzy (name and state)
- Federal award recipient: MYOMO INC Fuzzy (name and state)
- Form D issuer: MYOMO INC EXACT (CIK (EXACT))
- Lobbying client: MYOMO, INC. Fuzzy (name and state)
- Lobbying client: MYOMO, INC. Fuzzy (name and state)
- SEC filer: MYOMO INC EXACT (CIK (EXACT))
- Person page: Paul R Gudonis Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer))
- Person page: William J Febbo Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 27
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2017-10-20 | S-1 | S-1 (registration) | MYOMO INC | 0001213900-17-010801 ↗ |
| 2017-11-15 | S-1/A | S-1/A (amendment) | MYOMO INC | 0001213900-17-012132 ↗ |
| 2017-11-20 | S-1/A | S-1/A (amendment) | MYOMO INC | 0001213900-17-012396 ↗ |
| 2017-11-24 | S-1/A | S-1/A (amendment) | MYOMO INC | 0001213900-17-012543 ↗ |
| 2017-11-29 | S-1/A | S-1/A (amendment) | MYOMO INC | 0001213900-17-012697 ↗ |
| 2017-11-29 | S-1MEF | S-1MEF (added securities) | MYOMO INC | 0001213900-17-012768 ↗ |
| 2017-11-29 | EFFECT | EFFECT (declared effective) | MYOMO INC | 9999999995-17-003078 ↗ |
| 2017-12-01 | 424B4 | 424B4 (final prospectus) | MYOMO INC | 0001213900-17-012857 ↗ |
| 2018-07-16 | EFFECT | EFFECT (declared effective) | MYOMO INC | 9999999995-18-001799 ↗ |
| 2019-12-16 | S-1 | S-1 (registration) | MYOMO INC | 0001193125-19-315334 ↗ |
| 2020-01-14 | S-1/A | S-1/A (amendment) | MYOMO INC | 0001193125-20-007317 ↗ |
| 2020-02-03 | S-1/A | S-1/A (amendment) | MYOMO INC | 0001193125-20-022213 ↗ |
| 2020-02-07 | S-1/A | S-1/A (amendment) | MYOMO INC | 0001193125-20-028287 ↗ |
| 2020-02-10 | S-1/A | S-1/A (amendment) | MYOMO INC | 0001193125-20-029196 ↗ |
| 2020-02-10 | S-1/A | S-1/A (amendment) | MYOMO INC | 0001193125-20-029794 ↗ |
| 2020-02-10 | S-1MEF | S-1MEF (added securities) | MYOMO INC | 0001193125-20-030172 ↗ |
| 2020-02-10 | EFFECT | EFFECT (declared effective) | MYOMO INC | 9999999995-20-000299 ↗ |
| 2020-02-12 | 424B4 | 424B4 (final prospectus) | MYOMO INC | 0001193125-20-033415 ↗ |
| 2021-05-25 | EFFECT | EFFECT (declared effective) | MYOMO, INC. | 9999999995-21-002111 ↗ |
| 2022-12-07 | S-1 | S-1 (registration) | MYOMO, INC. | 0001193125-22-300231 ↗ |
| 2023-01-04 | S-1/A | S-1/A (amendment) | MYOMO, INC. | 0001193125-23-001339 ↗ |
| 2023-01-10 | S-1/A | S-1/A (amendment) | MYOMO, INC. | 0001193125-23-005448 ↗ |
| 2023-01-11 | S-1/A | S-1/A (amendment) | MYOMO, INC. | 0001193125-23-005775 ↗ |
| 2023-01-11 | S-1MEF | S-1MEF (added securities) | MYOMO, INC. | 0001193125-23-006589 ↗ |
| 2023-01-11 | EFFECT | EFFECT (declared effective) | MYOMO, INC. | 9999999995-23-000110 ↗ |
| 2023-01-13 | 424B4 | 424B4 (final prospectus) | MYOMO, INC. | 0001193125-23-008486 ↗ |
| 2024-08-28 | EFFECT | EFFECT (declared effective) | MYOMO, INC. | 9999999995-24-002664 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-11-29 | S-1/A | registration statement | $4.33 | 2,000,000 | $8,660,000 | NYSE American MYO | 2 | primary document; price sentence, shares headline, proceeds computed, cover names 2 | document ↗ | |
| 2017-12-01 | 424B4 | final prospectus | $2.40 | 4,175,000 | $10,020,000 | NYSE American MYO | 1 | primary document; price line, shares headline, proceeds computed, underwriting table 1, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Crowley Thomas Aloysius Jr. | Director | 17 | 2017–2026 | ||
| GOLDWASSER RALPH A | Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER | 7 | 2017–2019 | |
| GUDONIS PAUL R | Director,Officer; Officer | Chief Executive Officer; CHIEF EXECUTIVE OFFICER | 36 | 2017–2026 | person page Fuzzy |
| KIRK THOMAS F | Director | 27 | 2017–2026 | ||
| Knapp Amy K. | Director | 8 | 2017–2024 | ||
| Mendelsohn Davie | Officer | VP, Sales; VP, SALES & CLINICAL SERVICES | 4 | 2017–2019 | |
| Naft Jonathan | Officer | VICE PRESIDENT, GM; VP, General Manager; VP, GENERAL MANAGER | 7 | 2017–2020 | |
| SANGHI STEVE | Director | 7 | 2017–2019 | ||
| MGC Venture Partners 2013, L.P. | Other; TenPercentOwner | 2 | 2017–2018 | ||
| Green Brandon M | Officer | Chief Medical Officer | 6 | 2017–2020 | |
| CONNEIGHTON CLIFF | Officer | Chief Marketing Officer | 10 | 2017–2021 | |
| Mitchell Micah | Officer | Chief Commercial Officer; Chief Commerical Officer | 32 | 2018–2026 | |
| HENRY DAVID A | Officer | Chief Financial Officer | 31 | 2019–2026 | |
| Kovelman Harry | Officer | Chief Medical Officer | 66 | 2021–2026 | |
| Morris Milton Mayo | Director | 9 | 2021–2026 | ||
| Jacobovitz Yitzchak | Director | 1 | 2023 | ||
| Getz Heather C | Director | 6 | 2024–2026 | ||
| FEBBO WILLIAM J | Director | 3 | 2026 | person page Fuzzy | |
| Manko Joseph M. Jr. | Director | 3 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2016-07-15 | MYOMO INC | Other Health Care | $3,000,000 | $200,000 | 2 | 1 |
| 2016-01-07 | MYOMO INC | Other Health Care | $1,500,000 | $620,000 | 6 | 1 |
| 2014-08-05 | MYOMO INC | Other Health Care | $5,250,000 | $1,720,231 | 37 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | MYOMO INC | MA | Form D private offerings | CIK (EXACT) |
| SEC filer | MYOMO, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | MYOMO INC. | State business registries | name and state | |
| Federal award recipient | MYOMO INC | Federal spending (USAspending) | name and state | |
| Lobbying client | MYOMO, INC. | Federal lobbying (LDA) | name and state | |
| Lobbying client | MYOMO, INC. | Federal lobbying (LDA) | name and state | |
| Person page | Paul R Gudonis | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer) | |
| Person page | William J Febbo | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Orthopedic, Prosthetic & Surgical Appliances & Supplies, MA first:
- INNOVASIVE DEVICES INC MA
- Inogen Inc MA
- Conformis Inc MA
- Bone Biologics Corp MA
- Bionik Laboratories Corp. MA
- Lifeward Ltd. MA
- Vicarious Surgical Inc. MA
- BioHorizons, Inc. AL
- LAKELAND INDUSTRIES INC AL
- ALIGN TECHNOLOGY INC AZ
In other datasets, the same topic (Technology) in MA:
- Form D issuer: 10 Percent Happier, Inc. (Form D private offerings)
- Lobbying client: 5G ACTION NOW (Federal lobbying (LDA))
Interests: Orthopedic, Prosthetic & Surgical Appliances & Supplies · Technology